An Optimized Peptide Antagonist of CXCR4 Limits Survival of BCR–ABL1-Transformed Cells in Philadelphia-Chromosome-Positive B-Cell Acute Lymphoblastic LeukemiaJohanna Pohl, Moumita Datta|International Journal of Molecular Sciences|2024Cited by 8